欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号ES/H/0137/001
药品名称Potassium chloride 150 mg/ml Concentrate for solution for injection or infusion
活性成分
    • potassium chloride 150.0 mg/ml
剂型Concentrate for solution for injection/infusion
上市许可持有人Fresenius Kabi España, S.A. c/Marina, 16-18, planta 17 Torre Mapfre 08005 Barcelona (Spain)
参考成员国 - 产品名称Spain (ES)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Portugal (PT)
    • Poland (PL)
      Kalium chloratum 15%Kabi
    • Latvia (LV)
      Potassium chloride Kabi150 mg/ml koncentrāts infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Potassium chloride Kabi 150 mg/ ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      POTASSIUM CHLORIDE KABI 150 MG/ML
    • Romania (RO)
      Clorura de potasiu Kabi 150 mg/ml concentrat pentru solutie injectabila sau perfuzabila
许可日期2010/05/04
最近更新日期2023/04/17
药物ATC编码
    • B05XA01 potassium chloride
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase